Shao-Chieh Juan

Title: Innovations of Shao-Chieh Juan

Introduction

Shao-Chieh Juan is a notable inventor based in Moorpark, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. With a total of 3 patents, his work has the potential to impact various medical treatments.

Latest Patents

One of his latest patents is focused on the Interleukin-1β converting enzyme-like cysteine protease, known as LICE3. This invention identifies a new member of a family of ICE-like cysteine proteases. The LICE3 polypeptides, along with nucleic acids encoding LICE3, vectors, and host cells for its expression, are disclosed in this patent. Additionally, methods for identifying LICE3 agonists and antagonists, as well as treatment methods for disorders characterized by altered apoptosis, are also included. Another significant patent involves anti-inflammatory CD14 polypeptides. This invention relates to soluble CD14-related polypeptides that have amino acids at positions 7-10 differing from the native sequence or have amino acids 1-14 deleted.

Career Highlights

Shao-Chieh Juan has established himself as a key figure in his field through his innovative research and development efforts. He is currently associated with Amgen Inc., a leading biotechnology company known for its focus on human therapeutics. His work at Amgen has allowed him to contribute to groundbreaking advancements in medical science.

Collaborations

Shao-Chieh has collaborated with esteemed colleagues such as Samuel D Wright and Henri S Lichenstein. These partnerships have fostered a collaborative environment that enhances the potential for innovative discoveries.

Conclusion

Shao-Chieh Juan's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapeutic agents.